Long-Term Outcomes of Neonatal Abstinence Syndrome: Implications for Providers and Caregivers

Learn about the epidemiology, clinical presentation, treatment and long-term outcomes of infants with neonatal abstinence syndrome (NAS) in the U.S. Opportunities for prevention and early intervention will be discussed.

Speakers:

Margaret (Peggy) Honein, PhD, MPH 

Director, Division of Congenital and Developmental Disorders, Centers for Disease Control and Prevention 

Mary-Margaret A. Fill, MD  

Medical Epidemiologist, Tennessee Department of Health

Michael Warren, MD, MPH, FAAP

Associate Administrator, Maternal and Child Health Bureau, Health Resources and Services Administration

Rebecca Russell, MSPH

(Moderator), SVP (Interim) Science and Strategy Senior Director, Applied Research and Evaluation, March of Dimes

Session Goals:

Learn about the epidemiology, clinical presentation, treatment and long-term outcomes of infants with neonatal abstinence syndrome (NAS) in the U.S. Opportunities for prevention and early intervention will be discussed.

Learning Objectives:

1. Discuss CDC’s role in protecting mothers and babies in the context of the opioid epidemic.
2. Review the clinical presentation and treatment options for infants with Neonatal Abstinence Syndrome.
3. Discuss possible long-term outcomes of Neonatal Abstinence Syndrome.
4. Outline opportunities for prevention or early intervention in children and families at risk for Neonatal Abstinence Syndrome.

A live webcast sponsored by:

March of Dimes and Clinical Directors Network, Inc. (CDN)

Date:

Monday, October 29, 2018 from 2:30 PM to 3:30 PM EDT

Slideset

Long-Term Outcomes of Neonatal Abstinence Syndrome: Implications for Providers and Caregivers (PDF)

This webcast is approved for up to 1.0 Prescribed CME credits by the American Academy of Family Physicians (AAFP). Please Click Here to complete the evaluation for enduring CME credits, which are ANCC recognized. Enduring Credits valid until October, 29, 2019.

Recent Webcasts